CTOs on the Move


 
uBiome is the leading microbial genomics company. We are pioneering a new era of microbiome-based precision medicine. We allow doctors, patients, and citizen scientists to learn about the human microbiome with unprecedented accuracy and speed.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

uBiome raised $26.62M on 11/02/2016
uBiome raised $83M on 09/21/2018

Similar Companies

NorthStar EMS

NorthStar EMS is a Humble, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Pharmacy Insurance Corporation of America - PICA

Pharmacy Insurance Corporation of America - PICA is a San Juan, PR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CareRev

CareRev is a marketplace technology that connects hospitals and health systems and local, vetted healthcare professionals on demand. We help our customers build a more flexible and resilient workforce by lowering premium labor costs, automating staffing operations, and building a modern-day float pool powered by technology.

Alnylam

Alnylam is the world`s leading RNAi therapeutics company and the first and only company to bring an RNAi medicine to market. We are developing RNAi (RNA interference) as an innovative, entirely new class of medicines to treat rare genetic, cardio metabolic, acute hepatic infectious and central nervous system (CNS) and ocular diseases. Alnylam was founded in 2002 based on a Nobel Prize-winning breakthrough in biology – the discovery of RNAi, and a bold vision that this discovery could be used to silence disease-causing genes upstream of today`s medicines. We are relentless in our pursuit of new treatments because we believe that RNAi therapeutics can be used to treat many diseases for which treatment options do not exist or are inadequate. Overall, we believe that patients shouldn`t have to wait for hope. Alnylam is turning scientific possibility into reality - in 2018, the FDA and European EMA approved of our first product, ONPATTRO (patisiran) which is also the first-ever approved RNAi therapeutic. In 2019, the FDA approved our second product, GIVLAARI (givosiran). Our robust pipeline of investigational medicines includes multiple programs in late-stage and early-stage clinical development. We are a global and diverse company of more than 1,500 people. We pride ourself on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That`s why we`ve been named a Science Magazine Top Employer for two years in a row (`19-`20), a Boston Globe Top Place to Work 5x in a row (`15-`19) and one of Fast Company`s 50 Most Innovative Companies for 2019. We are based in Cambridge, U.S., with offices throughout Europe, Asia and South America.

BeneChill

BeneChill is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.